Global Neuroprotection Market Analysis 2015-2019 and Forecast 2020-2025
Report Code: KNJ154346 | No. of Pages: 91 | Category: Pharmaceuticals and Healthcare
Publisher: 99Strategy | Date of Publish: Feb-2020
Snapshot
The global Neuroprotection market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neuroprotection by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
F. Hoffmann-La Roche
Biogen
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Prevention
Treatment
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Content

1 Industry Overview
1.1 Neuroprotection Industry
Figure Neuroprotection Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Neuroprotection
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Neuroprotection
1.2.2 Downstream
Table Application Segment of Neuroprotection
Table Global Neuroprotection Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neuroprotection Market by Type
3.1 By Type
3.1.1 Free Radical Trapping Agents (Antioxidants)
Table Major Company List of Free Radical Trapping Agents (Antioxidants)
3.1.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
Table Major Company List of Glutamate Antagonists (Anti-Excitotoxic Agents)
3.1.3 Apoptosis Inhibitors
Table Major Company List of Apoptosis Inhibitors
3.1.4 Anti-inflammatory Agents
Table Major Company List of Anti-inflammatory Agents
3.1.5 Neurotrophic Factors (NTFs)
Table Major Company List of Neurotrophic Factors (NTFs)
3.1.6 Metal Ion Chelators
Table Major Company List of Metal Ion Chelators
3.1.7 Stimulants
Table Major Company List of Stimulants
3.1.8 Others
Table Major Company List of Others
3.2 Market Size
Table Global Neuroprotection Market 2015-2019, by Type, in USD Million
Figure Global Neuroprotection Market Growth 2015-2019, by Type, in USD Million
Table Global Neuroprotection Market 2015-2019, by Type, in Volume
Figure Global Neuroprotection Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Neuroprotection Market Forecast 2020-2025, by Type, in USD Million
Table Global Neuroprotection Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Daiichi Sankyo Company (Company Profile, Sales Data etc.)
4.1.1 Daiichi Sankyo Company Profile
Table Daiichi Sankyo Company Overview List
4.1.2 Daiichi Sankyo Company Products & Services
4.1.3 Daiichi Sankyo Company Business Operation Conditions
Table Business Operation of Daiichi Sankyo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.2.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.2.2 Eli Lilly and Company Products & Services
4.2.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Allergan (Company Profile, Sales Data etc.)
4.3.1 Allergan Profile
Table Allergan Overview List
4.3.2 Allergan Products & Services
4.3.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
4.4.1 Dr. Reddy’s Laboratories Profile
Table Dr. Reddy’s Laboratories Overview List
4.4.2 Dr. Reddy’s Laboratories Products & Services
4.4.3 Dr. Reddy’s Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.5.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.5.2 Teva Pharmaceutical Products & Services
4.5.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis (Company Profile, Sales Data etc.)
4.6.1 Novartis Profile
Table Novartis Overview List
4.6.2 Novartis Products & Services
4.6.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 AstraZeneca (Company Profile, Sales Data etc.)
4.7.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.7.2 AstraZeneca Products & Services
4.7.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Astrocyte Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Astrocyte Pharmaceuticals Profile
Table Astrocyte Pharmaceuticals Overview List
4.8.2 Astrocyte Pharmaceuticals Products & Services
4.8.3 Astrocyte Pharmaceuticals Business Operation Conditions
Table Business Operation of Astrocyte Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.9.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.9.2 F. Hoffmann-La Roche Products & Services
4.9.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Biogen (Company Profile, Sales Data etc.)
4.10.1 Biogen Profile
Table Biogen Overview List
4.10.2 Biogen Products & Services
4.10.3 Biogen Business Operation Conditions
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Neuroprotection Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neuroprotection Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Neuroprotection Sales Revenue Share in 2019, by Company, in USD Million
Table Global Neuroprotection Sales Volume 2015-2019, by Company, in Volume
Table Global Neuroprotection Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Neuroprotection Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Neuroprotection Market Concentration, in 2019
Figure Europe Neuroprotection Market Market Concentration, in 2019
Figure Asia-Pacific Neuroprotection MMarket Concentration, in 2019
Figure South America Neuroprotection Market Concentration, in 2019
Figure Middle East & Africa Neuroprotection Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Prevention
Figure Neuroprotection Demand in Prevention, 2015-2019, in USD Million
Figure Neuroprotection Demand in Prevention, 2015-2019, in Volume
6.1.2 Demand in Treatment
Figure Neuroprotection Demand in Treatment, 2015-2019, in USD Million
Figure Neuroprotection Demand in Treatment, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Neuroprotection Demand Forecast 2020-2025, by Application, in USD Million
Figure Neuroprotection Market Growth 2020-2025, by Application, in USD Million
Figure Neuroprotection Market Share in 2025, by Application, in USD Million
Table Neuroprotection Demand Forecast 2020-2025, by Application, in Volume
Table Neuroprotection Market Growth 2020-2025, by Application, in Volume
Table Neuroprotection Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Neuroprotection Production 2015-2019, by Region, in USD Million
Table Neuroprotection Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Neuroprotection Market 2015-2019, by Region, in USD Million
Table Global Neuroprotection Market Share 2015-2019, by Region, in USD Million
Table Global Neuroprotection Market 2015-2019, by Region, in Volume
Table Global Neuroprotection Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Neuroprotection Market Size and Growth 2015-2019, in USD Million
Figure North America Neuroprotection Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Neuroprotection Market Size 2015-2019, by Country, in USD Million
Table North America Neuroprotection Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Neuroprotection Market Size and Growth 2015-2019, in USD Million
Figure Europe Neuroprotection Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Neuroprotection Market Size 2015-2019, by Country, in USD Million
Table Europe Neuroprotection Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Neuroprotection Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Neuroprotection Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Neuroprotection Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neuroprotection Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Neuroprotection Market Size and Growth 2015-2019, in USD Million
Figure South America Neuroprotection Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Neuroprotection Market Size 2015-2019, by Country, in USD Million
Table South America Neuroprotection Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Neuroprotection Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Neuroprotection Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Neuroprotection Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neuroprotection Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Neuroprotection Market Forecast 2020-2025, by Region, in USD Million
Table Neuroprotection Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : info@kandjmarketresearch.com